IMIDEX Announces FDA 510(k) Clearance for VisiRad™ XR, an AI-powered medical device to help radiologists detect lung nodules in chest X-rays

DENVER, Aug. 17, 2023 (GLOBE NEWSWIRE) -- IMIDEX, a leader in developing AI-based solutions to address lung cancer, announces that it has received FDA 510(k) clearance for its flagship VisiRad XR product. VisiRad XR is an AI-powered software that analyzes chest X-rays and highlights possible lung nodules and masses. Employing state-of-the-art machine learning techniques…